Sci-Group AS
Org no 988 214 205 | Oslo, Norway | E-post: jj@sci-group.no
Next-generation cryopreservation
With CryoEmbla, Sci-Group is developing a new freezing technology that enables efficient cryopreservation of cells without, or with strongly reduced use of chemical cryoprotective agents. Our freezing system minimizes exposure to cytotoxic additives, simplifies workflows, and supports safer applications in both research and clinical settings.
How does CryoEmbla work?
Designed and produced in Norway, the CryoEmbla technology challenges the conventional freezing methods that focus on pairing chemical cryoprotective agents (CPAs) with the optimal cooling rate. Our advanced cryopreservation system precisely regulates both temperature and ice formation time. This reduces cell damage during freezing, thereby preserving both viability and function of the cells without the addition of CPAs.
CryoEmbla enables a streamlined freezing protocol, completing sample freezing in under 15 minutes after which they can be transferred directly to the liquid nitrogen tank for long-term storage.
The CryoEmbla technology has been tested with significant results on various cell types, and is continuously being developed to meet the needs of research, industry, and clinical applications.
Key advantages of CryoEmbla
- Lower CPA requirements: Strongly decreasing the need for cryoprotective agents.
- Maintains cell viability: Demonstrated cell survival after thawing.
- Fast and efficient: Shortening the freezing process to under 15 minutes, versus several hours with conventional methods.
- Simplified workflow: Reducing the need for washing and handling, as well as fewer sources of error.
- Supports safer clinical use: Minimizing the risk of cytotoxic exposure for patients and simplifying regulatory processes.
Designed and produced in Norway, protected by international patents.
Preserves cells and tissues without the use of CPAs
– safer treatments for patients.
From several hours to minutes
– efficient freezing with significant cell survival.
Areas of application
Sci-Group’s technology opens new opportunities within:
- Cell and gene therapy
- Biobanking and research
- Production of vaccines
- Fertility treatment (IVF)
- Livestock breeding programs
- Conservation and biodiversity preservation
Patented and protected
The CryoEmbla technology is patented in both Europe and the USA, giving Sci-Group a unique position in a market with rapidly growing demand for safe, effective, and CPA-free cryopreservation solutions.
Join us – become a partner
Partner with us and expand your possibilities in the future of safe and efficient cryopreservation.
Interested? Leave your info here & we’ll get back to you.